GLI1 and acute promyelocytic leukemia: Investigating GLI-1 gene expression in relation to disease outcome in terms of patient’s response on day 28 (CR) and survival analysis was carried out on the 39 non-APL patients and revealed that GLI-1 was increased in those who did not achieve CR than those who were in CR after initial chemotherapy (p = 0.017).